NAMS

NASDAQStock

NewAmsterdam Pharma Company N.V.

$30.04-1.31 (-4.19%)

52-Week Range

$14.90
$41.45

Key Stats

Market Cap

3.5B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.07

Volume

364.9K

Avg Volume

990.5K

Performance

1M

-10.15%

3M

-15.84%

6M

+29.98%

YTD

-10.94%

1Y

+34.20%

3Y

+140.60%

5Y

+202.90%

Price Chart

ETF Exposure

NAMS is held by 24 ETFs

ETFFund NameWeight
SBIOALPS Medical Breakthroughs ETF2.27%
GURUGlobal X - Guru Index ETF1.23%
BBCVirtus Biotech Clinical Trials ETF0.62%
FYCFirst Trust Small Cap Growth AlphaDEX Fund0.56%
CGMMCapital Group U.S. Small and Mid Cap ETF0.55%
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.52%
FMEDFIDELITY DISRUPTIVE MEDICINE ETF0.49%
FYXFirst Trust Small Cap Core AlphaDEX Fund0.27%
IBBQInvesco Nasdaq Biotechnology ETF0.27%
IBBiShares Biotechnology ETF0.20%
FPXEFirst Trust IPOX Europe Equity Opportunities ETF0.20%
STXKStrive Small-Cap ETF0.11%
FADFirst Trust Multi Cap Growth AlphaDEX Fund0.11%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.05%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.02%
VHTVanguard Health Care ETF0.02%
WSMLiShares MSCI World Small-Cap ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.00%

About NAMS ETF Exposure

NewAmsterdam Pharma Company N.V. (NAMS) is held by 24 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 3.5B, NAMS is a widely held institutional stock. The stock currently trades at $30.04. Investors can gain exposure to NAMS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NAMS, sorted by portfolio weight.